VistaGen Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $24.71 on 08/07/23, while the lowest value for the same period was recorded at $1.62 on 06/26/23.
52-week price history of VTGN Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. VistaGen Therapeutics Inc’s current trading price is -78.63% away from its 52-week high, while its distance from the 52-week low is 225.93%. The stock’s price range during this period has spanned from $1.62 to $24.71. In the Healthcare sector, the VistaGen Therapeutics Inc’s shares surpassed a trading volume of approximately 1.23 million for the day, which was noticeably higher compared to the average daily volume of 9.0.27 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
VistaGen Therapeutics Inc (VTGN) has experienced a quarterly rise of 2.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 142.72M and boasts a workforce of 33 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.53, with a change in price of +2.00. Similarly, VistaGen Therapeutics Inc recorded 435,694 in trading volume during the last 100 days, posting a change of +60.98%.
Examining VTGN’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VTGN stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
VTGN Stock Stochastic Average
Today’s raw stochastic average for VistaGen Therapeutics Inc over the last 50 days is 77.82%.This indicates a increase from the raw stochastic average of the past 20 days, which was 77.82%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 51.87% and 37.09%, respectively.
VTGN Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 2.72%.However, over the last six months, we can see a weaker performance of 0.19%. Over the last 30 days, the price of VTGN has fallen by 1.34%. And in the last five days, it has surged by 25.27%.
